Ito Yasuhiro, Hirokawa Mitsuyoshi, Uruno Takashi, Kihara Minoru, Higashiyama Takuya, Takamura Yuuki, Miya Akihiro, Kobayashi Kaoru, Matsuzuka Fumio, Miyauchi Akira
Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe 650-0011, Japan.
World J Surg. 2008 Aug;32(8):1789-94. doi: 10.1007/s00268-008-9482-3.
A subtype of papillary thyroid carcinoma that is totally surrounded by a fibrous capsule is designated an encapsulated carcinoma. In this study, we investigated the biologic behavior and prognosis of this type of carcinoma.
The clinicopathologic parameters and prognosis were compared between 1207 patients with conventional papillary carcinoma and 149 patients diagnosed as having encapsulated papillary carcinoma who underwent initial surgery between 1987 and 1996.
Sex, age, and the tumor size of the encapsulated carcinoma did not differ from those of patients with conventional papillary carcinoma. However, none of the patients with encapsulated carcinoma showed distant metastasis at diagnosis. The incidences of pathologic lymph node metastasis and clinically apparent lateral node metastasis in patients with encapsulated carcinomas were significantly lower than in those with a conventional papillary carcinoma. Ten patients (6.7%) with encapsulated carcinoma showed recurrence after surgery. After excluding recurrence to the remnant thyroid, disease-free survival of patients with encapsulated carcinoma was significantly better than that of those with conventional papillary carcinoma. None of the patients with encapsulated carcinoma died of carcinoma.
Encapsulated papillary carcinoma exhibits a more indolent biologic behavior than conventional papillary carcinoma. However, because recurrence to locoregional and even distant organs can be seen, careful and constant postoperative follow-up is recommended.
一种完全被纤维性包膜包裹的甲状腺乳头状癌亚型被称为包膜内癌。在本研究中,我们调查了这种类型癌症的生物学行为和预后情况。
比较了1987年至1996年间接受初次手术的1207例传统乳头状癌患者和149例被诊断为包膜内乳头状癌患者的临床病理参数及预后情况。
包膜内癌患者的性别、年龄和肿瘤大小与传统乳头状癌患者无异。然而,包膜内癌患者在诊断时均未出现远处转移。包膜内癌患者的病理淋巴结转移和临床明显的侧方淋巴结转移发生率显著低于传统乳头状癌患者。10例(6.7%)包膜内癌患者术后出现复发。排除复发至残留甲状腺的情况后,包膜内癌患者的无病生存率显著优于传统乳头状癌患者。包膜内癌患者均未死于癌症。
包膜内乳头状癌的生物学行为比传统乳头状癌更为惰性。然而,由于可出现局部甚至远处器官的复发,建议术后进行仔细且持续的随访。